99 related articles for article (PubMed ID: 11701693)
1. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.
Gibril F; Venzon DJ; Ojeaburu JV; Bashir S; Jensen RT
J Clin Endocrinol Metab; 2001 Nov; 86(11):5282-93. PubMed ID: 11701693
[TBL] [Abstract][Full Text] [Related]
2. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
Bartsch DK; Fendrich V; Langer P; Celik I; Kann PH; Rothmund M
Ann Surg; 2005 Dec; 242(6):757-64, discussion 764-6. PubMed ID: 16327485
[TBL] [Abstract][Full Text] [Related]
3. Management of Gastric Neuroendocrine Tumors: A Review.
Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.
Lee L; Ito T; Jensen RT
Expert Rev Anticancer Ther; 2019 Dec; 19(12):1029-1050. PubMed ID: 31738624
[No Abstract] [Full Text] [Related]
5. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Clinical Spectrum of Primary Hyperparathyroidism.
Jha S; Simonds WF
Endocr Rev; 2023 Sep; 44(5):779-818. PubMed ID: 36961765
[TBL] [Abstract][Full Text] [Related]
7. Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES.
Ito T; Ramos-Alvarez I; Jensen RT
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900170
[TBL] [Abstract][Full Text] [Related]
8. Pancreaticoduodenectomy Is the Best Surgical Procedure for Zollinger-Ellison Syndrome Associated with Multiple Endocrine Neoplasia Type 1.
Kong W; Albers MB; Manoharan J; Goebel JN; Kann PH; Jesinghaus M; Bartsch DK
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454834
[TBL] [Abstract][Full Text] [Related]
9. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract][Full Text] [Related]
10. Distinct clinical phenotypes in a family with a novel truncating MEN1 frameshift mutation.
Welsch C; Flügel AK; Rondot S; Schulze E; Sircar I; Nußbaumer J; Bojunga J
BMC Endocr Disord; 2022 Mar; 22(1):64. PubMed ID: 35287658
[TBL] [Abstract][Full Text] [Related]
11. [The clinical practice guidelines for primary hyperparathyroidism, short version].
Mokrysheva NG; Eremkina AK; Mirnaya SS; Krupinova JA; Voronkova IA; Kim IV; Beltsevich DG; Kuznetzov NS; Pigarova EA; Rozhinskaya LY; Degtyarev MV; Egshatyan LV; Rumiantsev PA; Andreeva EN; Аntsiferov MB; Markina NV; Kryukova IV; Karonova TL; Lukyanov SV; Sleptcov IV; Chagai NB; Melnichenko GA; Dedov II
Probl Endokrinol (Mosk); 2021 Aug; 67(4):94-124. PubMed ID: 34533017
[TBL] [Abstract][Full Text] [Related]
12. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Murage E; Wu R; Dennison JB; Krishna H; Peterson CB; Lozano G; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Del Rivero J; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4969-e4980. PubMed ID: 34318891
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects of multiple endocrine neoplasia type 1.
Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
[TBL] [Abstract][Full Text] [Related]
14. Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort.
van Beek DJ; Nell S; Vorselaars WMCM; Bonsing BA; van Eijck CHJ; van Goor H; Nieveen van Dijkum EJ; Dejong CHC; Valk GD; ; Borel Rinkes IHM; Vriens MR
Ann Surg Oncol; 2021 Aug; 28(8):4387-4399. PubMed ID: 33521900
[TBL] [Abstract][Full Text] [Related]
15. Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations.
Mele C; Mencarelli M; Caputo M; Mai S; Pagano L; Aimaretti G; Scacchi M; Falchetti A; Marzullo P
Front Endocrinol (Lausanne); 2020; 11():591501. PubMed ID: 33312161
[TBL] [Abstract][Full Text] [Related]
16. Multiple Endocrine Neoplasia Type 1: Latest Insights.
Brandi ML; Agarwal SK; Perrier ND; Lines KE; Valk GD; Thakker RV
Endocr Rev; 2021 Mar; 42(2):133-170. PubMed ID: 33249439
[TBL] [Abstract][Full Text] [Related]
17. Surgical Management of Neuroendocrine Tumours of the Pancreas.
Souche R; Hobeika C; Hain E; Gaujoux S
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32947997
[TBL] [Abstract][Full Text] [Related]
18. Gastrinoma in multiple endocrine neoplasia type 1 after total pancreatectomy: A case report.
Gong S; Li Z; Liu XB; Wang X; Shen WW
Medicine (Baltimore); 2019 Dec; 98(50):e18275. PubMed ID: 31852099
[TBL] [Abstract][Full Text] [Related]
19. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).
van Beek DJ; Nell S; Pieterman CRC; de Herder WW; van de Ven AC; Dekkers OM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
J Surg Oncol; 2019 Nov; 120(6):966-975. PubMed ID: 31401809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
